Cubist Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.01.17	Sotheby's International Realty Expands Presence into New Market in Pennsylvania (PR Newswire)
21.01.15	Merck Closes Tender Offer To Buy Cubist Pharma - Quick Facts (RTTNews)
21.01.15	Dana Holding To Replace Cubist Pharma In S&P MidCap 400 (RTTNews)
20.12.14	Cubist Gets FDA Approval Of New Antibiotic Zerbaxa (RTTNews)
09.12.14	Merck Committed To Cubist Pharma Acquisition Despite Patent Ruling (RTTNews)
09.12.14	Merck Statement On Cubicin Patent Litigation; Cubist Deal To Proceed As Planned (RTTNews)
09.12.14	New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost (RTTNews)
09.12.14	MÄRKTE USA/Energiewerte drücken Wall Street ins Minus (Dow Jones)
08.12.14	MÄRKTE USA/Energiewerte drücken Wall Street ins Minus (Dow Jones)
08.12.14	Merck & Co., Inc. -- Moody's affirms Merck & Co.'s ratings; outlook stable (Moodys)
08.12.14	US-Pharmakonzern Merck übernimmt Antibiotika-Hersteller Cubist (AWP)
08.12.14	ROUNDUP/US-Pharmakonzern Merck übernimmt Antibiotika-Hersteller Cubist (dpa-afx)
08.12.14	MÄRKTE USA/Wall Street dürfte nach Rekordjagd eine Auszeit nehmen (Dow Jones)
08.12.14	Merck To Buy Cubist Pharma For $8.4 Bln (RTTNews)
08.12.14	Milliarden-Deal: US-Pharmakonzern Merck übernimmt Antibiotika-Hersteller Cubist (dpa-afx)
08.12.14	US-Pharmakonzern Merck kauft Cubist (AWP)
08.12.14	Merck To Acquire Cubist Pharma For $102 Per Share - Quick Facts (RTTNews)
06.12.14	Merck Reportedly Nears Deal To Buy Cubist Pharmaceuticals (RTTNews)
22.10.14	Cubist Pharma Turns To Profit In Q3, Results Beat View (RTTNews)
21.10.14	Cubist Pharma Reports Q3 Non-GAAP EPS Of $0.58 - Quick Facts (RTTNews)
20.10.14	Cubist Pharma Names COO Robert Perez CEO (RTTNews)
18.09.14	Cubist eröffnet internationalen Hauptsitz in Zürich (AWP)
07.08.14	BDSI Hoping To Deliver, MDCO Gets FDA Nod, TXMD On Watch, Busy Days Await NVAX (RTTNews)
10.05.14	Cubist Announces Positive Results From Ph 3 Trials Of Ceftolozane/Tazobactam (RTTNews)
23.04.14	Cubist Pharma Q1 Profit Surges (RTTNews)
22.04.14	Cubist Pharma. Q1 Profit Surges (RTTNews)
22.04.14	LLY Adds New Drug To Portfolio, GILD Faces FDA Decision, IMUC Catches Eyes (RTTNews)
21.04.14	Cubist Pharma Submits NDA For Investigational Antibiotic Ceftolozane/tazobactam (RTTNews)
18.04.14	Cubist Pharma Recalls One Lot Of Cubicin Due To Presence Of Particulate Matter (RTTNews)
01.04.14	Adherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines (RTTNews)
01.04.14	FDA Panel Unanimously Oks Approval For Two Antibiotics, Dalvance And Sivextro (RTTNews)
31.03.14	FDA Panel Backs Cubist's Antibiotic Sivextr (RTTNews)
27.02.14	Cubist Pharma Says EMA Accepts MAA For Tedizolid For Review - Quick Facts (RTTNews)
23.01.14	Cubist Pharma Posts Q4 Loss - Quick Facts (RTTNews)
13.01.14	Cubist Pharma Q4 Revenue Climbs 22% - Quick Facts (RTTNews)
13.01.14	ALNY Opens Wallet, MNKD Gets FDA Panel Date, STEM Keeps Growing (RTTNews)
30.12.13	Cubist Pharma: FDA Accepts NDA For Its Tedizolid, TR-701, With Priority Review (RTTNews)
17.12.13	ADHD Gets Attention, BioLife To Uplist Stock, TRGT Misses Goal, CEMP On A High (RTTNews)
16.12.13	Pre-market Movers For Dec 16 (AIG, CBST, PATH, SLTM, AVGO, LSI) (RTTNews)
16.12.13	Cubist Reports Positive Results From Phase 3 Trial Of Ceftolozane/Tazobactam (RTTNews)
26.11.13	Echo Sounds Louder, PBMD Gets Prime Attention, Xmas Coming Early For CYCC (RTTNews)
25.11.13	Cubist Pharma: Ceftolozane/tazobactam Met Primary Endpoint In Phase 3 Trial (RTTNews)
24.10.13	Cubist Pharma Completes Acquisition Of Optimer Pharmaceuticals (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	Cubist Pharma Reports Loss In Q3 On Higher Expenses - Quick Facts (RTTNews)
22.10.13	Oxygen Bio Breathes Anew, KERX Gets FDA Date, Rockwell Continues To Rock (RTTNews)
21.10.13	Cubist Pharma Reports FDA Approval For Expanded Use Of ENTEREG - Quick Facts (RTTNews)
15.10.13	Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc. (PR Newswire)
01.10.13	Merger Updates, Milestone Payments, AGM Results, Review of Strategic Alternatives and Other Corporate Announcements - Research Report on Cubist, Halozyme, Taro, Galena and Sequenom (PR Newswire)
30.09.13	Conference Calls, New Appointments, Agreements, Pricing of Offerings and New Clinical Trials - Research Report on Abbott, Cubist, Pacific Biosciences, Synageva, and Oncothyreon (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cubist Pharmaceuticals Inc.

Aktien Top/Flop

Cubist Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten